Recent Updates
Recently added Catalysts
ELDN Positive Sentiment

Extending Transplant Life Through Targeted Innovation

Key Takeaway: The article highlights the innovative efforts of ELDN in extending the life of organ transplants. It emphasizes the importance of patient stories and clinical trials in showcasing the impact of their work. The focus on targeted innovation aims to transform lives, one organ at a time.
Price reaction · baseline $3.795 (2025-07-24T17:21:00.000Z) · hit during market hours · clean, no other ELDN news in the window
day 0 close · peak
-1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Focus on transforming lives through organ transplantation.
  • Innovative approaches to extend transplant life.
  • Emphasis on patient stories and clinical trials.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+90%
120-day peak, hindsight
Typical move
6.5%
average across 7 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
AT-1501
Phase 2 · Kidney Transplant Rejection

Full Press Release Details

Transforming Lives. One Organ at a Time.
• Overview Focus Patient Stories Clinical Trials In The News
• Science Mechanism of Action Pipeline Publications & Presentations In The News
• Team Overview Leadership Board of Directors
• Investors Overview News & Events Press Releases Events Publications & Presentations Corporate Governance Governance Overview Committee Composition Ethics Hotline Financials SEC Filings Stock Information Stock Quote & Chart Analyst Coverage Resources Investor FAQs Email Alerts Contact IR
• Culture/Careers Culture Careers
• Contact
• Focus
• Patient Stories
• Clinical Trials
• In The News
• Mechanism of Action
• Pipeline
• Publications & Presentations
• In The News
• Overview
• Leadership
• Board of Directors
• Overview
• News & Events Press Releases Events Publications & Presentations
• Corporate Governance Governance Overview Committee Composition Ethics Hotline
• Financials SEC Filings
• Stock Information Stock Quote & Chart Analyst Coverage
• Resources Investor FAQs Email Alerts Contact IR
• Press Releases
• Events
• Publications & Presentations
• Governance Overview
• Committee Composition
• Ethics Hotline
• SEC Filings
• Stock Quote & Chart
• Analyst Coverage
• Investor FAQs
• Email Alerts
• Contact IR
• Culture
• Careers
• Privacy Overview
• Necessary
• Analytics
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.

Frequently Asked Questions

What is ELDN's focus in organ transplantation?

ELDN focuses on extending the life of organ transplants through targeted innovation.

How does ELDN showcase its impact?

ELDN highlights patient stories and clinical trials to demonstrate the impact of its innovations.

What is the goal of ELDN's innovations?

The goal is to transform lives by improving organ transplant outcomes.

Last updated: Jul 24, 2025